从百时美施贵宝求证到该公司已签署协议出售在中美上海施贵宝制药有限公司中持有的60%股权。百时美施贵宝表示公司对中国市场的

智通财经
Sep 15, 2025
从百时美施贵宝求证到该公司已签署协议出售在中美上海施贵宝制药有限公司中持有的60%股权。百时美施贵宝表示公司对中国市场的坚定承诺始终如一并将在公司“中国2030战略”指引下继续投资中国市场。未来仍将致力于加速引入广泛疾病领域的创新前沿疗法并全力提升药物可及性。(一财)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10